Articles on Health equity

Displaying 1 - 20 of 67 articles

Pooling procurement of drugs could increase the availability of essential treatments around the globe. narvo vexar/iStock via Getty Images Plus

When developing countries band together, lifesaving drugs become cheaper and easier to buy − with trade-offs

Pharmaceutical companies have little incentive to sell drugs to countries that can’t afford them. But bargaining together can increase access to vital treatments worldwide.
Medical staff look out from a window at Kenyatta National Hospital in Nairobi in March 2021 as officials prepare for a ceremony to commence the country’s first coronavirus vaccinations provided through the global COVAX initiative. (AP Photo/Ben Curtis)

Why it’s a critical time for Canada to renew its commitment to global health co-operation

Building on a storied history of engagement that supersedes partisan politics, there is no time to lose for Canada to strategically renew its role in global health.
Mpox virus particles seen through a microscope. Mpox is a virus that causes flu-like symptoms and skin blisters across the body. (NIAID)

The WHO has declared Mpox a ‘public health emergency of international concern.’ Is it time to worry?

The current Mpox situation is concerning, but there is not yet any reason for Canadians to panic. As the situation develops, listen to public health advice and be ready to take appropriate action.
During the pandemic, timely and accurate data on COVID-19 infectivity rates among different ethnic and racialized groups were insufficient. THE CANADIAN PRESS/Chris Young

Ethnicity, race and health equity: 3 lessons from the COVID-19 pandemic

The COVID-19 pandemic showed that a one-size-fits-all approach is inadequate for addressing health inequities. A targeted, community-informed strategy is essential to improve public health responses.
Racialized people are dsproportionately affected by diabetes, but are underrepresented in clinical studies. (Shutterstock)

Whose health matters? The diversity deficit in clinical trials

Diabetes trials are leaving out people who are most affected by diabetes, which creates a series of problems include the greater likelihood of missing rare and potentially dangerous side effects.

Top contributors

More